Overview
According to their own website, STELARA uses the monoclonal antibody known as ustekinumab to treat patients of Chron’s disease. A monoclonal antibody is a synthetic antibody that originated in a lab animal. In order to make one of these special antibodies, a lab animal would be immunized and then have its B cells isolated and combined with malignant myeloma cells. The B cells and myeloma cells fuse in an aminopterin-containing medium, resulting in the creation of hybridoma cells. Hybridoma cells are important because they proliferate with the same epitope every time, which is crucial when creating a monoclonal antibody drug, as they will always serve the same function.
How does STELARA Work?
Once injected into the patient, the ustekinumab antibodies in STELARA function by binding to, and blocking, p40 protein subunits on the cytokines IL-12 and IL-23. Chron’s disease patients have been observed to have higher levels of these cytokines. By binding to the p40 subunits, STELARA inhibits the innate, pro-inflammatory actions of IL-12 and IL-23 by blocking them from binding to their intended targets. These targets and actions of IL-12 and IL-23 include the activation of natural killer cells and helper T cells, as well as the differentiation of helper T cells.
STELARA Side-Effects
- Nasal Congestion
- Sore Throat
- Runny Nose
- Upper Respiratory Tract Infections
- Fever
- Headache
- Tiredness
- Itching
- Nausea and Vomiting
- Redness at Injection Site
- Yeast Infections
- UTIs
- Sinus Infections
- Bronchitis
- Diarrhea
- Stomach Pain
- Joint Pain
- Serious Allergic Reactions
- Lung Inflammation
- Reversible Posterior Leukoencephalopathy Syndrome (RPLS)
- Cancer
The function of STELARA is to suppress the immune response, thus, the patient is much more likely to contract minor and sever illnesses, such as TB. This is due to the body’s weakened ability to fight diseases while the immune system is suppressed by STELARA. While RPLS is seen more often in those taking STELARA, the company claims that the cause is unknown.
The side-effects of this drug are certainly scary, which is why doctor supervision and a prescription are required. It is fascinating how humans have the capability to engineer specific antibodies with specific epitopes so that certain diseases can be treated. It will be interesting to see if and how monoclonal antibody therapy is used in the future for treating more severe, life-threatening diseases.






